Is it Time to Dump Athira Pharma Inc (ATHA) Stock After it Has Fallen 12.98% in a Week?

The market has been down on Athira Pharma Inc (ATHA) stock recently. ATHA gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Athira Pharma Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ATHA!

See Full ATHA Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ATHA Stock Today?

Athira Pharma Inc (ATHA) stock is up 1.79% while the S&P 500 is lower by -0.02% as of 9:58 AM on Wednesday, Mar 20. ATHA is higher by $0.04 from the previous closing price of $2.24 on volume of 199,592 shares. Over the past year the S&P 500 is up 31.02% while ATHA is lower by -12.31%. ATHA lost -$3.09 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Athira Pharma Inc click here.

More About Athira Pharma Inc

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Click Here to get the full Stock Report for Athira Pharma Inc stock.